Need of Beta 3 Agonist in Today's World as Oral Hypoglycaemic and Antiobesity


  • Govt. Medical College, Department of Pharmacology, Patiala, India


No Abstract.


no Keywords

Subject Discipline

Pharmacy and Pharmacology

Full Text:


Szepietowska B, Zhu W, Chan O, Horblitt A, Dziura J, Sherwin RS. Modulation of Beta Adrenergic Receptors in the Ventromedial Hypothalamus Influences Counter regulatory Responses to Hypoglycemia. Diabetes journal 2011;60: 3154-8.

Bahare RS, Gupta J, Malik S, Sharma N. New Emerging Targets for Type-2 Diabetes. International Journal of PharmTech Research 2011;3(2):809-18.

Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nature Med 2013;19:1252–63.

Coman OA, Paunescu H, Ghita I, Coman L, Badararu A, Fulga I. Beta 3 adrenergic receptors: molecular, histological, functional and pharmacological approaches. Romanian Journal of Morphology and Embryology 2009;50(2):169–79.

Abete I, Santiago NC, Marti A, Martinez JA. Nutrigenetics and Nutrigenomics of Caloric Restriction. Progress in Molecular Biology and Translational Science 2012;108:323-46.

Kurylowicz A. Stimulation of Thermogenesis via Beta-Adrenergic and Thyroid Hormone Receptors Agonists in Obesity Treatment – Possible Reasons for Therapy Resistance. J Pharmacogenomics Pharmacoproteomics 2015;6(1):1-7.


  • There are currently no refbacks.